IFNG and neoplasm: It is reported that the disruption of the CARMA1–BCL10–MALT1 (CBM) signalosome complex and induction of IFNγ secretion suppress Tregs, activate the adaptive immune response, hinder tumor growth, and improve the efficacy of immune checkpoint therapy (147).